Fenofibrate Monograph
Introduction Fenofibrate is a lipid‑lowering agent classified within the fibrate drug family. It functions primarily as a peroxisome proliferator‑activated receptor alpha (PPAR‑α) agonist, thereby modulating lipid metabolism at the transcriptional level. The compound was first synthesized in the mid‑20th century and entered clinical practice in the 1970s as a therapeutic option for hyperlipidemia. Over subsequent…